NCI National Clinical Trials Network (NCTN) Program Guidelines
NCI National Clinical Trials Network (NCTN) Program Guidelines NCI National Clinical Trials Network (NCTN) Program Guidelines
PART 2: Submission of New/Competing Application Section II –Budget & Research Plan Canadian Collaborating Clinical Trials Network G. Canadian Collaborating Clinical Trials Network Application The budget and research plan for this component are essentially the same as for the Network Group Operations Center and associated Statistics and Data Management Centers s (Operations Center and SDMC) although the volume of clinical trials, accrual, and collaborations would be expected to be more limited. In addition, the Canadian partner would be expected to establish relationships with U.S. Network Group Operations Centers to provide appropriate regulatory oversight for U.S. Networks trials conducted in Canada when needed and this budget component should be explained and justified in the application budget. 1. Detailed Budget for the Initial Budget Period Applicants for the Canadian Collaborating Clinical Trials Network should prepare their budgets following the budget section for the Network Group Operations Center provided in Part 2 – Section II.B.1. of these Guidelines and the budget section for the Network Group Statistics and Data Management Center provided in Part 2 – Section II.C.1. of these Guidelines, with appropriate adjustments. 2. Research Plan In the “Research Plan” section of the Canadian Collaborating Clinical Trials Network ‘s application, a Specific Aims page should be provided as well as separate PHS 398 Research Strategy Sections for the 5 sub-sections listed below within the corresponding specified page limits (and the Table of Contents for the Research Plan section of the application should be modified accordingly). The 5 sub-sections listed below consist of an Operations Center Overview and 4 required functional components of an Operations Center & SDMC - i.e., (1) Clinical Trial Development & Member Site Accrual Program, (2) Operational Management, (3) Statistics Analysis Program and Data Management, and (4) Program for Collaborations and Participation in Collective Management). Table of Contents for the Network Group Operations Center application only Specific Aims (including Impact Statement) - 1 page Research Strategy Section for the Canadian Collaborating Clinical Trials Network Application This section must consist of the sub-sections A-E described below. A. Operations, Statistics, and Data Management Center Overview - 6 pages B. Clinical Trial Development & Member Site Accrual Program- 12 pages C. Operational Management – 12 pages D. Statistics Analysis Program and Data Management - 12 pages E. Program for Collaborations and Participation in Collective Management - 12 pages Other sections of the PHS 398 Research Plan (398 application instructions Part I, Section 5.5), such as the sections for Letters of Support (e.g., Letter of Support from the institution or organization sponsoring the Network Groups Operations Center) and Multiple Program Director/Principal Investigator (PD(s)/PI(s) Leadership Plan, remain unmodified and must be completed following standard instructions. 2.1 Sub-section A. Operations, Statistics, and Data Management Center Overview (up to 6 pages) This sub-section should provide a general overview of the Operations, Statistics, and Data Management Center of the Canadian Collaborating Clinical Trials Network organization and describe the general features and operations of the organization. The applicant should provide a diagram illustrating the organizational structure of the organization in this sub- Page 144 of 241
PART 2: Submission of New/Competing Application Section II –Budget & Research Plan Canadian Collaborating Clinical Trials Network section and describe how the Canadian Collaborating Clinical Trials Network would interact with the other key components of the NCTN Program. The applicant’s key standard operating procedures for the conduct of clinical trials related to the following should be provided in the Resource section of the application: � Data and Safety Monitoring Board Policy for Phase 3 Trials & Randomized Phase 2 Trials � Data and Safety Monitoring Plan for Phase 1 and Phase 2 Trials � Conflict of Interest Policy � Onsite Auditing Policy and Procedures � Constitution & By-laws for Institution/Site Membership and Individual Participant/Investigator Membership (including Scientific and Administrative Committee Membership) � Standard Template for the Informed Consent Document � Procedures for Statistical Analysis (e.g., guidelines for interim monitoring, general � procedures for sample size estimation, accrual rate estimation, and choice of testing and estimation procedures) � Data Management and Monitoring Policies & Procedures for Clinical Trials � Procedures to Ensure Security and Confidentiality of Patient Data � Model Statistical Analysis Template for Clinical Trials � Sample of Trial Reports (i.e., 3 trials) from the SDMC Report of Studies 2.2 Sub-section B. Clinical Trial Development & Member Site Accrual Program (up to 12 pages) This sub-section should consist of a well-defined research strategy by the applicant for the development of clinical trials with a specific research focus and patient populations that complement the research strategy of the U.S. NCTN Program. In particular, the applicant should address how its research agenda will complement the NCTN Program as a whole even though the applicant would be expected to participate in only a limited portion of the NCTN Program. The applicant should address how it decides what research collaborations to pursue with the NCTN Program. The applicant should highlight its most important achievements over the past 5 to 6 years as well as its most promising current and future research initiatives and trials as an indication of its potential to contribute to the NCTN Program. This sub-section should also include information on the applicant’s senior research teams (for scientific research committees and administrative committees) and the applicant should also describe how it will mentor new/young investigators in clinical trial research. NOTE: Information on the applicant’s scientific leadership in clinical trial development as well as achievements of its past (over the prior 5 to 6 years) and current clinical trial development program may be summarized in tables. Use of template Tables #1, #2, #3, and #4 as described in Part 4 - Appendices – Section II.A. of these Guidelines for the NCTN Program is highly recommended and may be included in the Resources section of the application. This sub-section should also consist of a well-defined plan for accrual to NCTN trials by the applicant's member institutions/sites. This plan should encompass accrual to the occasional trial led by the applicant as well as trials that will be led by U.S. Network Groups Operations Centers. Emphasis should be placed on overall accrual across the entire NCTN. This subsection should present information on the potential of the applicant to accrue patients to oncology clinical treatment trials and advanced imaging trials in a publicly funded clinical trials system across a broad range of diseases, including rare cancers, via its member institutions/sites. Page 145 of 241
- Page 93 and 94: PART 1: Overview of NCTN Program Se
- Page 95 and 96: PART 2: Submission of Competing New
- Page 97 and 98: PART 2: Submission of Competing New
- Page 99 and 100: PART 2: Submission of Competing New
- Page 101 and 102: PART 2: Submission of New/Competing
- Page 103 and 104: PART 2: Submission of New/Competing
- Page 105 and 106: PART 2: Submission of New/Competing
- Page 107 and 108: PART 2: Submission of New/Competing
- Page 109 and 110: PART 2: Submission of New/Competing
- Page 111 and 112: PART 2: Submission of New/Competing
- Page 113 and 114: PART 2: Submission of New/Competing
- Page 115 and 116: PART 2: Submission of New/Competing
- Page 117 and 118: PART 2: Submission of New/Competing
- Page 119 and 120: PART 2: Submission of New/Competing
- Page 121 and 122: PART 2: Submission of New/Competing
- Page 123 and 124: PART 2: Submission of New/Competing
- Page 125 and 126: PART 2: Submission of New/Competing
- Page 127 and 128: PART 2: Submission of New/Competing
- Page 129 and 130: PART 2: Submission of New/Competing
- Page 131 and 132: PART 2: Submission of New/Competing
- Page 133 and 134: PART 2: Submission of New/Competing
- Page 135 and 136: PART 2: Submission of New/Competing
- Page 137 and 138: PART 2: Submission of New/Competing
- Page 139 and 140: PART 2: Submission of New/Competing
- Page 141 and 142: PART 2: Submission of New/Competing
- Page 143: PART 2: Submission of New/Competing
- Page 147 and 148: PART 2: Submission of New/Competing
- Page 149 and 150: PART 2: Submission of New/Competing
- Page 151 and 152: PART 2: Submission of New/Competing
- Page 153 and 154: PART 2: Submission of New/Competing
- Page 155 and 156: PART 2: Submission of New/Competing
- Page 157 and 158: PART 2: Submission of New/Competing
- Page 159 and 160: PART 2: Submission of New/Competing
- Page 161 and 162: PART 2: Submission of New/Competing
- Page 163 and 164: PART 2: Submission of New/Competing
- Page 165 and 166: PART 2: Submission of New/Competing
- Page 167 and 168: PART 2: Submission of New/Competing
- Page 169 and 170: PART 2: Submission of New/Competing
- Page 171 and 172: PART 2: Submission of New/Competing
- Page 173 and 174: PART 2: Submission of New/Competing
- Page 175 and 176: PART 2: Submission of New/Competing
- Page 177 and 178: PART 2: Submission of New/Competing
- Page 179 and 180: PART 2: Submission of New/Competing
- Page 181 and 182: PART 2: Submission of New/Competing
- Page 183 and 184: PART 2: Submission of New/Competing
- Page 185 and 186: PART 2: Submission of New/Competing
- Page 187 and 188: PART 3: Submission of Non-Competing
- Page 189 and 190: TYPE OF STUDY PART 3: Submission No
- Page 191 and 192: PART 3: Submission Non-Competing Ap
- Page 193 and 194: PART 3: Submission Non-Competing Ap
PART 2: Submission of New/Competing Application Section II –Budget & Research Plan<br />
Canadian Collaborating <strong>Clinical</strong> <strong>Trials</strong> <strong>Network</strong><br />
G. Canadian Collaborating <strong>Clinical</strong> <strong>Trials</strong> <strong>Network</strong> Application<br />
The budget and research plan for this component are essentially the same as for the <strong>Network</strong> Group<br />
Operations Center and associated Statistics and Data Management Centers s (Operations Center and<br />
SDMC) although the volume of clinical trials, accrual, and collaborations would be expected to be<br />
more limited. In addition, the Canadian partner would be expected to establish relationships with<br />
U.S. <strong>Network</strong> Group Operations Centers to provide appropriate regulatory oversight for U.S.<br />
<strong>Network</strong>s trials conducted in Canada when needed and this budget component should be explained<br />
and justified in the application budget.<br />
1. Detailed Budget for the Initial Budget Period<br />
Applicants for the Canadian Collaborating <strong>Clinical</strong> <strong>Trials</strong> <strong>Network</strong> should prepare their budgets<br />
following the budget section for the <strong>Network</strong> Group Operations Center provided in Part 2 –<br />
Section II.B.1. of these <strong>Guidelines</strong> and the budget section for the <strong>Network</strong> Group Statistics and<br />
Data Management Center provided in Part 2 – Section II.C.1. of these <strong>Guidelines</strong>, with<br />
appropriate adjustments.<br />
2. Research Plan<br />
In the “Research Plan” section of the Canadian Collaborating <strong>Clinical</strong> <strong>Trials</strong> <strong>Network</strong> ‘s<br />
application, a Specific Aims page should be provided as well as separate PHS 398 Research<br />
Strategy Sections for the 5 sub-sections listed below within the corresponding specified page<br />
limits (and the Table of Contents for the Research Plan section of the application should be<br />
modified accordingly). The 5 sub-sections listed below consist of an Operations Center Overview<br />
and 4 required functional components of an Operations Center & SDMC - i.e., (1) <strong>Clinical</strong> Trial<br />
Development & Member Site Accrual <strong>Program</strong>, (2) Operational Management, (3) Statistics<br />
Analysis <strong>Program</strong> and Data Management, and (4) <strong>Program</strong> for Collaborations and Participation in<br />
Collective Management).<br />
Table of Contents for the <strong>Network</strong> Group Operations Center application only<br />
Specific Aims (including Impact Statement) - 1 page<br />
Research Strategy Section for the Canadian Collaborating <strong>Clinical</strong> <strong>Trials</strong> <strong>Network</strong> Application<br />
This section must consist of the sub-sections A-E described below.<br />
A. Operations, Statistics, and Data Management Center Overview - 6 pages<br />
B. <strong>Clinical</strong> Trial Development & Member Site Accrual <strong>Program</strong>- 12 pages<br />
C. Operational Management – 12 pages<br />
D. Statistics Analysis <strong>Program</strong> and Data Management - 12 pages<br />
E. <strong>Program</strong> for Collaborations and Participation in Collective Management - 12 pages<br />
Other sections of the PHS 398 Research Plan (398 application instructions Part I, Section 5.5),<br />
such as the sections for Letters of Support (e.g., Letter of Support from the institution or<br />
organization sponsoring the <strong>Network</strong> Groups Operations Center) and Multiple <strong>Program</strong><br />
Director/Principal Investigator (PD(s)/PI(s) Leadership Plan, remain unmodified and must be<br />
completed following standard instructions.<br />
2.1 Sub-section A. Operations, Statistics, and Data Management Center Overview (up to 6<br />
pages)<br />
This sub-section should provide a general overview of the Operations, Statistics, and Data<br />
Management Center of the Canadian Collaborating <strong>Clinical</strong> <strong>Trials</strong> <strong>Network</strong> organization and<br />
describe the general features and operations of the organization. The applicant should<br />
provide a diagram illustrating the organizational structure of the organization in this sub-<br />
Page 144 of 241